{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:10:54Z","timestamp":1781179854365,"version":"3.54.1"},"reference-count":21,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.2463\/mrms.mp.2019-0049","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T22:04:06Z","timestamp":1571090646000},"page":"227-234","source":"Crossref","is-referenced-by-count":5,"title":["Prediction of Hypoxia in Brain Tumors Using a Multivariate Model Built from MR Imaging and &lt;sup&gt;18&lt;\/sup&gt;F-Fluorodeoxyglucose Accumulation Data"],"prefix":"10.2463","volume":"19","author":[{"given":"Yukie","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Radiation Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital"},{"name":"Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kameda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Fujima","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Toyonaga","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin Khin","family":"Tha","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital"},{"name":"Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shirato","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, Hokkaido University Graduate School of Medicine"},{"name":"Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lee CT, Boss MK, Dewhirst MW. Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal 2014; 21:313\u2013337.","DOI":"10.1089\/ars.2013.5759"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008; 8:425\u2013437.","DOI":"10.1038\/nrc2397"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gerstner ER, Zhang Z, Fink JR, et al. ACRIN 6684: assessment of tumor hypoxia in newly diagnosed glioblastoma using <sup>18<\/sup>F-FMISO PET and MRI. Clin Cancer Res 2016; 22:5079\u20135086.","DOI":"10.1158\/1078-0432.CCR-15-2529"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kobayashi H, Hirata K, Yamaguchi S, Terasaka S, Shiga T, Houkin K. Usefulness of FMISO-PET for glioma analysis. Neurol Med Chir (Tokyo) 2013; 53:773\u2013778.","DOI":"10.2176\/nmc.ra2013-0256"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hirata K, Terasaka S, Shiga T, et al. <sup>18<\/sup>F-fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging 2012; 39:760\u2013770.","DOI":"10.1007\/s00259-011-2037-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Spence AM, Muzi M, Swanson KR, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 2008; 14:2623\u20132630.","DOI":"10.1158\/1078-0432.CCR-07-4995"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Toyonaga T, Yamaguchi S, Hirata K, et al. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor. Eur J Nucl Med Mol Imaging 2017; 44:611\u2013619.","DOI":"10.1007\/s00259-016-3541-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bekaert L, Valable S, Lechapt-Zalcman E, et al. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. Eur J Nucl Med Mol Imaging 2017; 44:1383\u20131392.","DOI":"10.1007\/s00259-017-3677-5"},{"key":"9","unstructured":"9. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004; 25:746\u2013755."},{"key":"10","unstructured":"10. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21:891\u2013899."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shiroishi MS, Habibi M, Rajderkar D, et al. Perfusion and permeability MR imaging of gliomas. Technol Cancer Res Treat 2011; 10:59\u201371.","DOI":"10.7785\/tcrt.2012.500180"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Colliez F, Fruytier AC, Magat J, et al. Monitoring combretastatin A4-induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE-MRI. Magn Reson Med 2016; 75:866\u2013872.","DOI":"10.1002\/mrm.25642"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ellingsen C, Hompland T, Galappathi K, Mathiesen B, Rofstad EK. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts. Radiother Oncol 2014; 110:335\u2013341.","DOI":"10.1016\/j.radonc.2013.10.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ponte KF, Berro DH, Collet S, et al. In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study. J Nucl Med 2017; 58: 1574\u20131579.","DOI":"10.2967\/jnumed.116.188557"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rajendran JG, Mankoff DA, O\u2019Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [<sup>18<\/sup>F]-fluoromisonidazole and [<sup>18<\/sup>F]-fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 2004; 10:2245\u20132252.","DOI":"10.1158\/1078-0432.CCR-0688-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015; 73:102\u2013116.","DOI":"10.1002\/mrm.25197"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Herholz K. Brain tumors: an update on clinical PET research in gliomas. Semin Nucl Med 2017; 47:5\u201317.","DOI":"10.1053\/j.semnuclmed.2016.09.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamaguchi S, Hirata K, Toyonaga T, et al. Change in <sup>18<\/sup>F-fluoromisonidazole PET Is an early predictor of the prognosis in the patients with recurrent high-grade glioma receiving bevacizumab treatment. PLoS One 2016; 11:e0167917.","DOI":"10.1371\/journal.pone.0167917"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bell C, Dowson N, Fay M, et al. Hypoxia imaging in gliomas with <sup>18<\/sup>F-fluoromisonidazole PET: toward clinical translation. Semin Nucl Med 2015; 45:136\u2013150.","DOI":"10.1053\/j.semnuclmed.2014.10.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Swanson KR, Chakraborty G, Wang CH, et al. Complementary but distinct roles for MRI and <sup>18<\/sup>F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med 2009; 50:36\u201344.","DOI":"10.2967\/jnumed.108.055467"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumors. Nat Rev Neurosci 2007; 8:610\u2013622.","DOI":"10.1038\/nrn2175"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/19\/3\/19_mp.2019-0049\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T03:48:38Z","timestamp":1596858518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/19\/3\/19_mp.2019-0049\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.mp.2019-0049","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}